dj Orthopedics Strengthens Its Board of Directors With The Addition of Lewis Parker and Benjamin B. Edmands

SAN DIEGO, June 4 /PRNewswire-FirstCall/ -- dj Orthopedics, Inc. (NYSE: DJO), a designer, manufacturer and marketer of products and services for the orthopedic sports medicine market, today announced the addition of Lewis Parker and Benjamin B. Edmands to its Board of Directors. Mr. Parker will serve as an independent director and will also serve on the audit committee of the Company's Board of Directors. Mr. Edmands will serve as a representative of J.P. Morgan Partners, LLC, the Company's largest stockholder.

Mr. Parker brings over forty years of related experience to the dj Orthopedics Board. The majority of Mr. Parker's career has been in finance and business development, serving a cross section of the healthcare industry including businesses in medical supplies and equipment, medical device manufacturing, biotechnology and orthopedics. Mr. Parker most recently served as director, vice president and chief financial officer for American Osteomedix Corporation, a medical technology venture, which was sold to Interpore Cross in July 2001. From 1996 to 2000, Mr. Parker was an independent consultant specializing in corporate turnaround situations. From 1991 to 1995, Mr. Parker was employed by Kirschner Medical Corporation, serving as president from 1994 to 1995 after the company was acquired by Biomet, Inc. Previously, Mr. Parker held several other senior level management positions within the healthcare industry. He has been chief financial officer for two publicly traded companies. Mr. Parker received his undergraduate degree, with honors, in Civil Engineering from Lehigh University and his MBA in Finance from the Wharton School of the University of Pennsylvania.

Mr. Edmands is currently a Principal at J.P. Morgan Partners, LLC where he focuses on investments in the healthcare infrastructure sector. J.P. Morgan Partners is the private equity division of J.P. Morgan Chase & Co. and is one of the largest private equity organizations in the United States. J.P. Morgan Partners has invested over $1.4 billion in more than 170 companies in the life sciences and healthcare industries. Prior to joining J.P. Morgan Partners, LLC, Mr. Edmands held positions in Chemical Bank's Acquisition Finance Group. Mr. Edmands holds a B.A. with honors from Colgate University and a MBA with honors from Columbia Business School.

"Following the successful implementation of our performance improvement program in 2002, much of our 2003 focus will be aimed at accelerating the Company's revenue growth within our core business segments," said Les Cross, president and chief executive officer of dj Orthopedics. "We are privileged to have these two gentlemen join our board at such an important time; Lew with his successful track record in our industry and Ben representing J.P. Morgan Partners, our largest shareholder. We look forward to their contributions."

About dj Orthopedics, Inc.

dj Orthopedics is a global orthopedic sports medicine company specializing in the design, manufacture and marketing of products and services that rehabilitate soft tissue and bone, help protect against injury, and treat osteoarthritis of the knee. Its broad range of more than 600 existing products, many of which are based on proprietary technologies includes rigid knee braces, soft goods, specialty and other complementary orthopedic products. These products provide solutions for patients and orthopedic sports medicine professionals throughout the patient's continuum of care.

SOURCE dj Orthopedics, Inc.

Company Investor/Media Contact:
DJO Incorporated
Mark Francois
Director of Corporate Communications & Investor Relations
760-734-4766

Mark.Francois[at]djoglobal[dot]com